Back to Search
Start Over
Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits
- Publication Year :
- 2023
-
Abstract
- The original version of this article contained a mistake. The first affiliation should be changed to Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. The original article has been corrected. © 2023, The Author(s), under exclusive licence to Springer Nature Limited.
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1376637995
- Document Type :
- Electronic Resource